Categories AlphaGraphs, Earnings, Health Care

ABBV Earnings: Highlights of AbbVie’s Q2 2022 financial results

Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) has reported double-digit growth in second-quarter adjusted earnings, reflecting an increase in revenues. The company also provided earnings guidance for fiscal 2022.

Abbvie Q2 2022 earnings infographics

Total revenues increased 5% year-over-year to $14.6 billion, aided by a strong performance by the immunology and neuroscience segments.

At $3.37 per share, adjusted net income was up 11% year-over-year. Unadjusted profit increased sharply to $924 million or $0.51 per share from $766 million or $0.42 per share in the second quarter of 2021.


Check this space to read management/analysts’ comments on AbbVie’s Q2 2022 earnings


“We delivered another strong quarter with substantial progress for our new products and indications. Importantly, Skyrizi and Rinvoq continued their impressive ramps and are on pace to deliver approximately $7.5 billion in combined annual sales, underscoring their significant potential,” said Richard A. Gonzalez, CEO of AbbVie.

Most Popular

Key takeaways from General Mills’ Q3 2023 earnings report

Shares of General Mills Inc. (NYSE: GIS) were up nearly 3% on Thursday after the company delivered better-than-expected results for the third quarter of 2023 and raised its full-year guidance

FIVE Stock: Five Below is likely to continue the good show this year

For Five Below Inc. (NASDAQ: FIVE), the holiday season was more rewarding than expected as the high inflation and stressed personal finances made customers seek value. Earlier, the discount store

Earnings: Chewy (CHWY) swings to profit in Q4 on higher revenues

Chewy Inc. (NYSE: CHWY) has reported higher sales for the fourth quarter of 2022. Reflecting the strong top-line growth, the pet food company turned to profit from a loss last

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top